BIOMAT Database Logo BIOMAT Database Logo

Vaccination in Patients with Inflammatory Bowel Diseases. 2020

Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Cantonal Hospital of Frauenfeld, Frauenfeld, Switzerland, christine.manser@stgag.ch.

During the course of disease, a majority of inflammatory bowel disease (IBD) patients requires long-term immunosuppressive therapy with either immunomodulatory agents, biologics, or newer immunosuppressive therapies such as Vedolizumab, a selective α4β7 inhibitor, Ustekinumab, an IL 12/23 p40 inhibitor, or the Janus kinase inhibitor Tofacitinib. Due to this, they are at increased risk for infectious diseases, many of which are possible to prevent by vaccination. This review focuses on recommended vaccinations in IBD patients and stresses special issues which have to be paid attention to. The aim of the review is to increase gastroenterologists' awareness of the importance of vaccination and to stress why especially the gastroenterologist should assess the vaccination status of the patient and initiate vaccination as soon as diagnosis is established.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069549 Ustekinumab A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies. CNTO 1275,CNTO-1275,Stelara
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D015212 Inflammatory Bowel Diseases Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS. Bowel Diseases, Inflammatory,Inflammatory Bowel Disease

Related Publications

Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
Vaccination in Patients With Inflammatory Bowel Disease.
September 2020, The American journal of gastroenterology,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.
August 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
Vaccination of patients with inflammatory bowel disease.
January 2016, Journal of the American Pharmacists Association : JAPhA,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
Vaccination of Patients With Inflammatory Bowel Disease.
July 2017, Gastroenterology & hepatology,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
Exploring Vaccination in Patients With Inflammatory Bowel Disease.
February 2024, Gastroenterology & hepatology,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases.
November 2021, Medicine,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES.
January 2020, Arquivos de gastroenterologia,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
A comprehensive review of vaccination in patients with inflammatory bowel diseases:  An Indian perspective.
August 2020, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
The Who and Why of Herpes Zoster Vaccination in Patients With Inflammatory Bowel Diseases.
December 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Christine N Manser, and Michel H Maillard, and Gerhard Rogler, and Philipp Schreiner, and Florian Rieder, and Silja Bühler, and
Leukocytapheresis in patients with inflammatory bowel diseases.
January 2021, Przeglad gastroenterologiczny,
Copied contents to your clipboard!